News & Updates

Treatment with the 5-HT1 receptor agonist buspirone in patients with gastroparesis falls short of reducing symptoms including moderate-to-severe early satiety/postprandial fullness, according to a study.

Women with low levels of omega-3 in early pregnancy may lower their risk of early preterm birth by taking supplements, as suggested in a study.

An antiretroviral stewardship programme led by an HIV-specialized pharmacist can improve the safety of people living with HIV (PLHIV) by reducing medication errors, as shown in a Singapore study presented at ECCMID 2023.

A linear pharmacokinetics characterizes tremelimumab, a cytotoxic T-lymphocyte-associated protein 4 human monoclonal antibody of the immunoglobulin G2 κ isotype, in patients with advanced solid tumours, reveals a study.

Adding dostarlimab, an immune checkpoint inhibitor, to standard-of-care chemotherapy significantly improves progression-free survival (PFS) in patients with primary advanced or recurrent endometrial cancer, including those with dMMR-MSI-H* disease, according to the first interim analysis of the ENGOT-EN6-NSGO/GOG-3031/RUBY trial presented at SGO 2023.

In the treatment of patients with familial hypercholesterolemia, adding alirocumab to high-intensity statin therapy leads to a significant reduction in plaque burden and plaque stabilization, according to data from the ARCHITECT* study.